Antibodies & immunoassays for small molecules We are a collective of passionate and eclectic immunologists and scientists coming together to unlock new set of possibilities in research, diagnostics and therapy through small molecule antibodies development.
Executive team
Alban Bessede, PhD Founder,
Chief Executive Officer
Born and bred in Bordeaux, Alban founded ImmuSmol immediately after a post-doc in Sydney. Trained in immunology, he gained expertise in small molecule antibodies in the course of his research in oncology and neurodegeneration, eventually leading him to envisage their use in diagnostics and therapy.
Dominique Bodet, PhD
Study Director
Over his career, Dominique developed over 70 small molecule antibodies. Initially trained in biochemistry and immunology, he has overseen all ImmuSmol lab operations, from antigen design up to in vivo studies, since the inception of the company in 2012.
Board of directors
Vincent Picq, MSc
Founder, Chairman of Schiever
Vincent Picq has been supporting ImmuSmol since the very beginning. Head of a retailing group with annual sales exceeding €1,3 billion, he is providing ImmuSmol with strategic, management and administrative support.